Axplora

𝗪𝗵𝗲𝗻 𝘆𝗼𝘂𝗿 𝗔𝗣𝗜 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗽𝘂𝗿𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻, “𝗴𝗼𝗼𝗱 𝗲𝗻𝗼𝘂𝗴𝗵” 𝗶𝘀𝗻’𝘁 𝗴𝗼𝗼𝗱 𝗲𝗻𝗼𝘂𝗴𝗵. Faced with a complex, high-value API, our client needed more than a classic purification approach. Together, we developed a robust, automated two-step chromatography strategy delivering high purity and high yield — while building a process ready for what comes next: transfer, scale-up and clinical progress. 🚀 Because for an early-stage biotech, solving today’s challenge is only half the job. The process has to be ready for tomorrow. That problem-solving expertise is backed by 30+ years in industrial chromatography, thousands of cGMP batches delivered, and 20+ API manufacturing processes validated using chromatography. 📥 Download the case study to see how we turned a complex purification challenge into a robust manufacturing strategy → https://bit.ly/4yG2LKr 📍 Connect with our team at CPHI Milan if you’re working through a complex purification, development or scale-up challenge. 𝗥𝗲𝗮𝗰𝘁𝗶𝗼𝗻 𝘁𝗼 𝗥𝗲𝗮𝗹𝗶𝘁𝘆. 𝗕𝘂𝗶𝗹𝘁 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽. #Chromatography #ProcessDevelopment #APIManufacturing #Biotech #CPHI

🚀 𝚂𝚘𝚖𝚎 𝚓𝚘𝚞𝚛𝚗𝚎𝚢𝚜 𝚍𝚘𝚗'𝚝 𝚓𝚞𝚜𝚝 𝚎𝚡𝚙𝚕𝚘𝚛𝚎 𝚗𝚎𝚠 𝚠𝚘𝚛𝚕𝚍𝚜. 𝚃𝚑𝚎𝚢 𝚑𝚎𝚕𝚙 𝚌𝚑𝚊𝚗𝚐𝚎 𝚖𝚒𝚕𝚕𝚒𝚘𝚗𝚜 𝚘𝚏 𝚕𝚒𝚟𝚎𝚜 𝚘𝚗 𝙴𝚊𝚛𝚝𝚑. 🌎 3... 2... 1... Destination: CPHI Milan. Turning bold ideas into life-changing medicines takes more than ambition. It takes the right manufacturing partner. Across 9 manufacturing sites delivering clinical and commercial APIs, backed by 100+ years of combined manufacturing expertise, Axplora is a trusted partner to 900 customers—including 8 of the world's top 10 pharma companies. And we're not stopping there. By investing €180 million across our manufacturing network (2022–2027), we're continuing to strengthen our state-of-the-art facilities, helping customers navigate increasingly complex API manufacturing challenges. 🛰️ Ready to explore your next manufacturing challenge? Book a meeting with our team before CPHI through our contact page → www.axplora.com Because every breakthrough begins with people who #DareToImagine what's possible. 📍 Hall 3 | Booth 3C1 #CPHI #CDMO #API #Manufacturing #Pharma

With 105 m³ of installed HPAPI manufacturing capacity—one of the world's largest—and trusted by over 70 CDMO customers worldwide, Axplora is ready to support your journey from clinical to commercial 🚀

Biopharma companies have a clear superpower 🪄 discovering and developing breakthrough molecules. Ours? 👉 making sure they reach patients through them—at scale, without delay. At Axplora, we believe in a simple idea: 𝗙𝗼𝗰𝘂𝘀 𝗼𝗻 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗶𝗻𝗴 𝗮𝗻𝗱 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀. 𝗪𝗲’𝗹𝗹 𝗵𝗮𝗻𝗱𝗹𝗲 𝘁𝗵𝗲 𝘀𝗰𝗮𝗹𝗲-𝘂𝗽 𝗮𝗻𝗱 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴. From early development to commercial manufacturing, it’s about combining strengths to deliver what matters most—faster access to life-changing therapies. 🎥 Watch the full conversation on Fierce Pharma with Martin Meeson (CEO) and Arul Ramadurai (CCO). #Pharma #CDMO #Biotech #Manufacturing #Innovation #PatientImpact

Get the latest jobs and industry news

The journey from tech transfer to commercial launch requires expertise to navigate turbulence. Axplora provides the steady hand and technical depth to keep therapeutic checkpoints clear with precision and speed. Meet our global crew at DCAT Week.